Glimepiride Cristers

Glimepiride Cristers is a prescription oral medication containing the active ingredient glimepiride, a sulfonylurea class antidiabetic drug, marketed in the European Union. It is supplied as tablets (strength not specified) and is used to improve blood glucose control in adults with type 2 diabetes mellitus. The formulation works by stimulating insulin release from pancreatic beta‑cells.

Glimepiride Cristers is indicated for the management of type 2 diabetes mellitus when diet, exercise, and other oral agents are insufficient to achieve glycemic targets.

- Used as monotherapy in patients who cannot tolerate metformin. - Added to existing metformin therapy to enhance glucose control. - May be combined with other oral antihyperglycemic agents such as DPP‑4 inhibitors. - Intended for adults with adequate pancreatic beta‑cell function. - Helps reduce fasting and post‑prandial blood glucose levels.

Glimepiride Cristers may cause a range of side effects, some of which are common and others that require immediate medical attention.

Common: - Mild hypoglycemia, especially when meals are skipped. - Nausea or abdominal discomfort. - Headache or dizziness. - Weight gain. - Skin rash or pruritus.

Serious: - Severe hypoglycemia with confusion, seizures, or loss of consciousness. - Allergic reactions such as angioedema or Stevens‑Johnson syndrome. - Hepatotoxicity indicated by jaundice or elevated liver enzymes. - Hematologic abnormalities like leukopenia or thrombocytopenia.

Before starting Glimepiride Cristers, certain precautions should be considered to minimize risks.

- Assess renal and hepatic function; dose adjustment may be needed in impairment. - Use cautiously in elderly patients due to increased hypoglycemia risk. - Avoid in patients with known sulfonylurea hypersensitivity. - Monitor blood glucose regularly, especially during dose changes. - Counsel patients on recognizing and managing hypoglycemia. - Discontinue during pregnancy or breastfeeding unless clearly indicated.

Glimepiride Cristers can interact with several drug classes, influencing its efficacy or safety profile.

Avoid: - Concurrent use with other sulfonylureas or insulin, which may precipitate severe hypoglycemia. - Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that increase glimepiride plasma levels. - MAO‑B inhibitors, which can potentiate hypoglycemic effects.

Use with caution: - Beta‑blockers, as they may mask hypoglycemia symptoms. - Thiazide diuretics, which can raise blood glucose. - Corticosteroids or oral contraceptives that may reduce glimepiride effectiveness. - Alcohol, which can potentiate hypoglycemia, especially on an empty stomach.